Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;53(10):4529-32.
doi: 10.1128/AAC.00624-09. Epub 2009 Aug 3.

In vitro activities of panduratin A against clinical Staphylococcus strains

Affiliations

In vitro activities of panduratin A against clinical Staphylococcus strains

Yaya Rukayadi et al. Antimicrob Agents Chemother. 2009 Oct.

Abstract

In vitro antistaphylococcal activities of panduratin A, a natural chalcone compound isolated from Kaempferia pandurata Roxb, were compared to those of commonly used antimicrobials against clinical staphylococcal isolates. Panduratin A had a MIC at which 90% of bacteria were inhibited of 1 microg/ml for clinical staphylococcal isolates and generally was more potent than commonly used antimicrobials.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Structure of panduratin A.

References

    1. Archer, G. L., and M. W. Climo. 2005. Staphylococcus epidermidis and other coagulase negative staphylococci, p. 2352-2362. In G. L. Mandel, J. E. Bennet, and R. Dolin (ed.), Principles and practice of infection disease. Elsevier Churchill Livingston, Philadelphia, PA.
    1. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 384-404. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
    1. Clinical and Laboratory Standards Institute. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. CLSI, Wayne, PA.
    1. Emori, T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442. - PMC - PubMed
    1. French, G. L. 2006. Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin. J. Antimicrob. Chemother. 58:1107-1117. - PubMed